BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31238251)

  • 1. Biomedical applications of radioiodinated peptides.
    Oliveira MC; Correia JDG
    Eur J Med Chem; 2019 Oct; 179():56-77. PubMed ID: 31238251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiometallated peptides for molecular imaging and targeted therapy.
    Correia JD; Paulo A; Raposinho PD; Santos I
    Dalton Trans; 2011 Jun; 40(23):6144-67. PubMed ID: 21350775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceutical development of radiolabelled peptides.
    Fani M; Maecke HR
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.
    Tornesello AL; Tornesello ML; Buonaguro FM
    Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of peptide and protein based radiopharmaceuticals.
    Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
    Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.
    Liu N; Wan Q; Cheng Z; Chen Y
    Curr Top Med Chem; 2019; 19(1):17-32. PubMed ID: 30706786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabelling of glucose-Tyr3-octreotate with 125I and analysis of its metabolism in rats: comparison with radiolabelled DOTA-Tyr3-octreotate.
    Petrik M; Laznickova A; Laznicek M; Zalutsky MR
    Anticancer Res; 2007; 27(6B):3941-6. PubMed ID: 18225554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
    de Visser M; Verwijnen SM; de Jong M
    Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals.
    Bolzati C; Carta D; Salvarese N; Refosco F
    Anticancer Agents Med Chem; 2012 Jun; 12(5):428-61. PubMed ID: 22292757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.
    Eberle AN; Mild G; Froidevaux S
    J Recept Signal Transduct Res; 2004; 24(4):319-455. PubMed ID: 15648449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic groups for radioiodination and astatination of peptides and proteins: A comparative study of five potential bioorthogonal labeling strategies.
    Navarro L; Berdal M; Chérel M; Pecorari F; Gestin JF; Guérard F
    Bioorg Med Chem; 2019 Jan; 27(1):167-174. PubMed ID: 30529152
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptide receptor radionuclide therapy: an overview.
    Dash A; Chakraborty S; Pillai MR; Knapp FF
    Cancer Biother Radiopharm; 2015 Mar; 30(2):47-71. PubMed ID: 25710506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled peptides: current and new perspectives.
    Opalinska M; Hubalewska-Dydejczyk A; Sowa-Staszczak A
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):153-167. PubMed ID: 28347132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled peptides in nuclear oncology: influence of peptide structure and labeling strategy on pharmacology.
    Maecke HR
    Ernst Schering Res Found Workshop; 2005; (49):43-72. PubMed ID: 15524210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor ligands for targeting breast tumours: a brief outlook on radioiodination strategies.
    Oliveira MC; Neto C; Gano L; Marques F; Santos I; Thiemann T; Santos AC; Botelho F; Oliveira CF
    Curr Radiopharm; 2012 Apr; 5(2):124-41. PubMed ID: 22280114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel route to radioiodinated [123I]-N-succinimidyl-3-iodobenzoate, a reagent for radioiodination of bioactive peptides.
    Al-Jammaz I; Al-Otaibi B; Amartey JK
    Appl Radiat Isot; 2002 Nov; 57(5):743-7. PubMed ID: 12433050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Nov; 30(8):861-8. PubMed ID: 14698790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
    Khan IU; Beck-Sickinger AG
    Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides, multimers and polymers.
    Dijkraaf I; Wester HJ
    Handb Exp Pharmacol; 2008; (185 Pt 2):61-92. PubMed ID: 18626599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.